DE602007011647D1 - Verfahren zur bestimmung der quantität und qualität von hybridomen - Google Patents

Verfahren zur bestimmung der quantität und qualität von hybridomen

Info

Publication number
DE602007011647D1
DE602007011647D1 DE602007011647T DE602007011647T DE602007011647D1 DE 602007011647 D1 DE602007011647 D1 DE 602007011647D1 DE 602007011647 T DE602007011647 T DE 602007011647T DE 602007011647 T DE602007011647 T DE 602007011647T DE 602007011647 D1 DE602007011647 D1 DE 602007011647D1
Authority
DE
Germany
Prior art keywords
endocytic compartments
hybridomas
endocytic
quality
green
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007011647T
Other languages
English (en)
Inventor
Robert ZOREC
Marko Kreft
Mateja Gabrijel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELICA BIOMEDICAL CT
Original Assignee
CELICA BIOMEDICAL CT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200600207A external-priority patent/SI22385B/sl
Application filed by CELICA BIOMEDICAL CT filed Critical CELICA BIOMEDICAL CT
Publication of DE602007011647D1 publication Critical patent/DE602007011647D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
DE602007011647T 2006-09-05 2007-09-05 Verfahren zur bestimmung der quantität und qualität von hybridomen Active DE602007011647D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200600207A SI22385B (sl) 2006-09-05 2006-09-05 Metoda za določanje deleža in kvalitete hibridomov ter uporaba hibridomov primerne kvalitete
EP07101015 2007-01-23
PCT/EP2007/059296 WO2008028929A1 (en) 2006-09-05 2007-09-05 Method for determining the quantity and quality of hybridomas as well as the use of hybridomas of suitable quality

Publications (1)

Publication Number Publication Date
DE602007011647D1 true DE602007011647D1 (de) 2011-02-10

Family

ID=38556356

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007011647T Active DE602007011647D1 (de) 2006-09-05 2007-09-05 Verfahren zur bestimmung der quantität und qualität von hybridomen

Country Status (4)

Country Link
EP (1) EP2069782B1 (de)
AT (1) ATE493650T1 (de)
DE (1) DE602007011647D1 (de)
WO (1) WO2008028929A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002353890A1 (en) 2001-10-26 2003-05-06 Cleveland Clinic Foundation Fused cells, methods of forming same, and therapie utilizing same
SI21661A (sl) * 2003-12-30 2005-06-30 Celica, D.O.O. Postopek za evaluacijo deleža hibridnih celic in celičnih izdelkov s konfokalno mikroskopijo in avtoklavabilna elektrofuzijska kamrica

Also Published As

Publication number Publication date
WO2008028929A1 (en) 2008-03-13
EP2069782B1 (de) 2010-12-29
EP2069782A1 (de) 2009-06-17
ATE493650T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
Carrion et al. Recreating the perivascular niche ex vivo using a microfluidic approach
JP2020515235A5 (de)
WO2007067992A3 (en) Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
Saalbach et al. Interaction of human Thy-1 (CD 90) with the integrin αvβ3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium
WO2006076691A8 (en) Irta-2 antibodies and their uses
UA99701C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с лигандом-1 запрограммированной гибели клеток (pd-l1)
Has et al. Research techniques made simple: immunofluorescence antigen mapping in epidermolysis bullosa
WO2006096754A3 (en) Stabilized aptamers to psma and their use as prostate cancer therapeutics
JP2016196468A5 (de)
EA200800094A1 (ru) Антитела cd19 и их использование
WO2006074418A3 (en) Ovr110 antibody compositions and methods of use
EA201591131A1 (ru) Днк-конструкции антитела и способ их применения
NZ614857A (en) Bispecific antibodies and methods for production thereof
SG11201808994YA (en) Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
WO2008030611A3 (en) Antibodies to bone morphogenic proteins and receptors therefor and methods for their use
DK1633784T3 (da) OVR110 antistofsammensætninger og -anvendelsesfremgangsmåder
EP3149167B1 (de) Gegen mage-a3peptid gerichtetes aptamer und verwendung davon
ATE493650T1 (de) Verfahren zur bestimmung der quantität und qualität von hybridomen
BR0313151A (pt) métodos e reagentes que se relacionam à inflamação e à apoptose
Kittrell et al. Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential
KR20190111036A (ko) 결합 폴리펩타이드 및 이의 제조 방법
WO2007076465A3 (en) Cln248 antibody compositions and methods of use
Munson et al. Introduction to exosomes and cancer
JP6767737B2 (ja) ヒト細胞の単離のためのマウス細胞のディプリーション